Sign in

CIK 0001422143

  • Non-accelerated filer
  • Smaller reporting company

Kura Oncology, Inc.

Sign in to watch
Ticker
KURA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
611547851
Phone
+1 858-500-8800
Business address
4930 DIRECTORS PLACE, SUITE 500, SAN DIEGO, CA, 92121
Former names
ZETA ACQUISITION CORP III
Open-market buys, last 90 days
$4,248,530
in 3 filings
Open-market sales, last 90 days
$1,978,236
in 12 filings, $396K under 10b5-1 plans

Net +$2,270,294. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 38 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2024-01-30 DALE STEPHEN Chief Medical Officer Sale −4,825 $21.55 $104K 38,817
2024-01-29 DALE STEPHEN Chief Medical Officer Sale −4,400 $17.80 $78K 46,400
2024-01-29 DALE STEPHEN Chief Medical Officer Sale −2,758 $17.80 $49K 43,642
2024-01-02 DALE STEPHEN Chief Medical Officer Grant or award · Option to purchase common stock +185,000 185,000
2023-02-16 DALE STEPHEN Chief Medical Officer Grant or award +23,125 50,800
2023-02-16 DALE STEPHEN Chief Medical Officer Grant or award · Option to purchase common stock +185,000 185,000
2023-01-27 DALE STEPHEN Chief Medical Officer Sale −4,385 $13.89 $61K 32,515
2023-01-27 DALE STEPHEN Chief Medical Officer Sale −4,840 $13.87 $67K 27,675
2022-01-26 DALE STEPHEN Chief Medical Officer Grant or award +36,900 36,900
2022-01-26 DALE STEPHEN Chief Medical Officer Grant or award · Option to purchase common stock +261,000 261,000
2021-01-26 DALE STEPHEN Chief Medical Officer Grant or award · Option to purchase common stock +100,000 100,000
2020-08-24 DALE STEPHEN Chief Medical Officer Grant or award · Option to purchase common stock +200,000 200,000

Page 1 of 1 · 12 trades